Episode summary
BI Weekend: Disney Earnings, Metsera Bidding War, Visa-Mastercard Deal | Bloomberg Intelligence
Bloomberg Intelligence
· · 37 min · Hosts: Paul Sweeney, Scarlet Fu · Guests: Geetha Ranganathan, Mary Ross Gilbert, Sam Fazeli, Jennifer Bartashus, Emily Mason, Matthew Palazola, Justin Teresi
Summary
Disney’s fourth-quarter results were presented as a mixed picture: the parks business remains the profit engine, with operating profit up 13% and 2026 guidance described as solid, but linear TV and uneven studio results are still weighing on the story. The guest said Disney’s bundling strategy, especially around streaming and ESPN, is central to driving subscriber growth, reducing churn, and supporting future pricing power, even as sports rights remain fragmented and disputes like the one with YouTube TV show Disney has leverage in distribution talks.
The rest of the show focused on consumer and market pressure points. A retail analyst said holiday spending looks healthy overall, with apparel likely benefiting, but Gen Z expects to cut spending 23% while millennials are only modestly retrenching. Off-price chains and online sales are holding up, though lower-income consumers are showing more strain. On the pharmaceutical side, the guest said Pfizer’s higher bid prevailed in the Metsera auction after FTC concerns complicated Novo Nordisk’s path, and argued obesity remains a major but not exclusive theme in pharma.
Other segments covered Tyson’s flat 2026 profit outlook, Circle’s sensitivity to falling rates because it earns mostly from treasury yields on USDC reserves, Berkshire Hathaway’s succession and cash pile under Warren Buffett’s quieter phase, and a Visa-Mastercard settlement that could reshape swipe fees, card acceptance, and surcharging across merchants and premium rewards cards.
Key takeaways
- A media analyst said Disney’s parks and streaming are strong enough to offset pressure from linear TV, but the studio slate still clouds the narrative.
- The guest said Disney’s bundling strategy is the main driver of future earnings growth because it helps cut churn and support price increases.
- A retail analyst said Gen Z plans to cut holiday spending by 23%, while apparel and off-price chains still look relatively resilient.
- The pharma analyst said Pfizer’s higher bid won Metsera partly because FTC concerns made Novo Nordisk’s deal riskier.
- The fintech reporter said Circle’s earnings are highly exposed to short-term rates because most revenue comes from reserve income on USDC.
- The antitrust analyst said the Visa-Mastercard settlement could let merchants reject premium cards or surcharge consumers, but court approval is still uncertain.
Notable quotes
“the parks business brings in about 60% of profits. Things seem to be going pretty strong there”
“40% of new subscribers actually take the Disney bundle and this is really going to be the strategy for them going forward”
“Gen Z is planning to cut back on their overall holiday spending by there that you know by 23% millennials just 1%”
“So if interest rates go down, you know, that shows up in earnings and that causes some concern for investors and analysts”
“This case has been going on for about 20 years now”
How the episode opens
Bloomberg Audio Studios podcasts radio news. This is Bloomberg Intelligence with Scarlett Fu and Paul Sweeney. How do you think the Fed is looking at tariffs, the uncertainty of tariffs?
Let's take a look at the sectors and how they perform. A lot of investors getting whipsawed every day by news events breaking market headlines and corporate news from across the globe. Could we see a market disruption, a market event?
Are people just too exuberant out there? You see some so-called lowquality stocks driving this short-term rally? Bloomberg Intelligence with Scarlet Fu and Paul Sweeney on Bloomberg Radio, YouTube, and Bloomberg Originals.
On today's Bloomberg Intelligence Show, we dig inside the big business stories impacting Wall Street and the global markets. Each and every week, we provide in-depth research and data on some of the 2,000 companies and 130 industries our analysts cover worldwide. Today, we'll look at how Fizer won a bidding war against the Danish drug maker Novo Nordisk for an obesity startup.
Plus, we'll break down how Visa and Mastercard reached a deal with retailers after 20 years of litigation. But first, we begin with earnings from the media and entertainment giant Walt Disney. This week, Disney reported fourth quarter sales that fell short of Wall Street estimates.
The company also said expenses from a slate of big budget movies, including a new Avatar picture, will weigh on results for the coming quarter. For more, we were joined by Githa Ranganathan, Bloomberg Intelligence senior media analyst. We first asked Etha for her take on Disney's most recent earnings report.
It came off as a little bit of a lackluster report. I mean, everything if you look at the fundamental drivers of the company, which is really the parks business brings in about 60% of profits. Things seem to be going pretty strong there.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- disney earnings
- metsera bidding war
- gen-z holiday spending
- retail staples earnings
- visa mastercard deal
Companies and tickers mentioned
- DIS
- NVO
- PFE
- TSN
- BRK-B
- BRK-A
- V
- MA
- Walt Disney
- Metsera
- Novo Nordisk
- Pfizer
- Tyson Foods
- Circle Internet Group
- Berkshire Hathaway
- Visa
- Mastercard
- Bloomberg L.P.
Watch the episode
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Bloomberg Intelligence
-
Anthropic’s IPO Is Said to Be About Six Times Oversubscribed | Bloomberg Intelligence -
Instant Reaction: Nvidia CEO Jensen Huang Ousted by Nvidia Board | Bloomberg Intelligence -
Nvidia’s Huang Ousted by Board in Move That Roils AI Economy | Bloomberg Intelligence -
CoreWeave Shares Soar After AI Computing Firm Eases Debt Fears | Bloomberg Intelligence -
Anthropic Targets $1.4 Trillion Valuation in Blockbuster IPO | Bloomberg Intelligence -
Nvidia Probe Into CEO Affair Raises Thorny Questions for AI | Bloomberg Intelligence
Bloomberg Intelligence, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.
